TORRENT PHARMACEUTICALS
Back to Income Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹10,728 Cr | ₹9,620 Cr | ₹8,508 Cr | ₹8,005 Cr | ₹7,939 Cr |
What is the latest Revenue of TORRENT PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹10,728 Cr |
| Mar2024 | ₹9,620 Cr |
| Mar2023 | ₹8,508 Cr |
| Mar2022 | ₹8,005 Cr |
| Mar2021 | ₹7,939 Cr |
How is Revenue of TORRENT PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹10,728 Cr | 11.51 | |
| Mar2024 | ₹9,620 Cr | 13.07 | |
| Mar2023 | ₹8,508 Cr | 6.29 | |
| Mar2022 | ₹8,005 Cr | 0.82 | |
| Mar2021 | ₹7,939 Cr | - | |
Compare Revenue of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹129,026.8 Cr | 0.3% | 1.6% | 12.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,494.0 Cr | -1.5% | -4.8% | -4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,514.0 Cr | -0.9% | -1.4% | 11.1% | Stock Analytics | |
| CIPLA | ₹121,574.0 Cr | -0.8% | -1.2% | 1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,919.0 Cr | -0.8% | 1.7% | -5.6% | Stock Analytics | |
| MANKIND PHARMA | ₹90,491.0 Cr | 0.8% | -3% | -26.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 0.3% |
1.6% |
12.1% |
| SENSEX | 0.7% |
0.5% |
9% |
You may also like the below Video Courses